AmgenvsZimmer Biomet

AMGN and ZBH stock compared: price, dividend, valuation and results, from SEC filings.

AMGN

Amgen Inc.

$443.89

Value $239B

-3.07%
AMGN's page

ZBH

Zimmer Biomet Holdings, Inc.

$103.32

Value $20.2B

+1.20%
ZBH's page

Amgen (AMGN) has a market value of $239B and Zimmer Biomet (ZBH) $20.2B. Over the last year, with dividends, AMGN moved +33.5% and ZBH +17.8%. The P/E is 25.5 for AMGN and 26.3 for ZBH. Dividend yield: AMGN 2.24%, ZBH 0.93%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    AMGN$239B

    ZBH$20.2B

    AMGN is 12 times ZBH

  • Revenue, 12 months

    AMGN$38.9B

    ZBH$8.6B

    AMGN is 4.5 times ZBH

  • Net income, 12 months

    AMGN$9.4B

    ZBH$767M

    AMGN is 12 times ZBH

  • Operating margin

    AMGN32.4%

    ZBH13.6%

    18.8 points apart

  • ROIC

    AMGN16.2%

    ZBH5.0%

    11.2 points apart

  • P/E

    AMGN25.5

    ZBH26.3

    About the same

  • Dividend yield

    AMGN2.2%

    ZBH0.9%

    1.3 points apart

  • 5-year return

    AMGN+149.9%

    ZBH-15.2%

    165.1 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

AMGN+149.9%

ZBH-15.2%

10020020222023202420252026
Returns by period
PeriodAMGNWith dividendsZBHWith dividends
1 year since November 17, 2025+33.5%Price +29.9%+17.8%Price +16.6%
3 years since November 17, 2023+81.6%+22.0% a yearPrice +67.3%-4.8%-1.6% a yearPrice -7.5%
5 years since November 17, 2021+149.9%+20.1% a yearPrice +115.7%-15.2%-3.2% a yearPrice -18.8%
10 years since November 18, 2016+308.8%+15.1% a yearPrice +205.6%+14.9%+1.4% a yearPrice +5.7%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

AMGNAmgenZBHZimmer Biomet

Valuation

AMGNZBH
Valuation
Price$443.89$103.32
Market value$239B$20.2B
Enterprise value (EV)$280B$27.3B
P/E25.526.3
P/E, 5-year median23.025.1
P/B16.71.6
EV/EBIT22.223.5
Free cash flow yield4.0%8.1%

Results and growth

AMGNZBH
Results and growth
Revenue, 12 months$38.9B$8.6B
Net income, 12 months$9.4B$767M
Free cash flow, 12 months$9.6B$1.6B
Earnings per share, 12 months$17.25$3.96
Revenue growth, year on year10.0%7.2%
Revenue growth a year, past+7.6%over 5 years+6.1%over 5 years
EPS growth a year, past+2.9%over 5 years–

Margins and returns on capital

AMGNZBH
Margins and returns on capital
Gross margin70.9%69.7%
Operating margin32.4%13.6%
Net margin24.1%9.0%
ROIC16.2%5.0%
ROE87.8%6.1%

Balance sheet

AMGNZBH
Balance sheet
Cash$13.2B$400M
Total debt$54.0B$7.5B
Net debt / EBITDA2.33.2
Interest cover4.8×–

Dividends and buybacks

AMGNZBH
Dividends and buybacks
Dividend yield2.2%0.9%
Dividend per share, 12 months$9.94$0.96
Dividend growth a year, past+8.1%over 5 years+0.0%over 5 years
Buyback yield–2.4%
Shareholder yield2.2%3.3%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: AMGN or ZBH

Didn't find what you were looking for?

Ask us
Which is bigger, Amgen or Zimmer Biomet?

By market value, Amgen ($239B) is about 11.8 times Zimmer Biomet ($20.2B), at today's prices.

How did AMGN and ZBH stock do over the last 10 years?

Since November 18, 2016, AMGN's price moved +205.6% and ZBH's +5.7%. With dividends: AMGN +308.8% (+15.1% a year), ZBH +14.9% (+1.4% a year). Past returns do not predict future ones.

Which pays the higher dividend, AMGN or ZBH?

The dividend yield at today's price is 2.24% for Amgen and 0.93% for Zimmer Biomet. Over the last twelve months they paid $9.94 and $0.96 per share.

What is the P/E of AMGN and ZBH?

At today's price, the P/E is 25.5 for AMGN and 26.3 for ZBH. The median of the last five years was 23.0 and 25.1, which shows where each stands against its own past.

Which has the higher profit margins, Amgen or Zimmer Biomet?

Over the last twelve months, the net margin was 24.1% for Amgen and 9.0% for Zimmer Biomet, and the operating margin 32.4% and 13.6%. Revenue was $38.9B and $8.6B.

Which is the better investment, Amgen or Zimmer Biomet?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.